MYPROMS-ES02: Safety and Efficacy of Basiliximab, Cyclosporine Microemulsion and Enteric-coated Mycophenolate Sodium (EC-MPS) Versus EC-MPS and Steroid Therapy in Kidney Transplant Recipients Who Are Hepatitis C Positive

NCT00284921 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

De Novo Kidney Transplant

Interventions

DRUG: Enteric-coated Mycophenolate sodium (EC-MPS)

Sponsor

Novartis Pharmaceuticals